Zobrazeno 1 - 10
of 17
pro vyhledávání: '"A. B. Sheremet"'
Autor:
Nailya A. Zigangirova, Nadezda L. Lubenec, Vladimir B. Beloborodov, Anna B. Sheremet, Stanislava A. Nelyubina, Nataliia E. Bondareva, Konstantin A. Zakharov, Sergey I. Luyksaar, Sergey A. Zolotov, Evgenia U. Levchenko, Svetlana V. Luyksaar, Ekaterina A. Koroleva, Elena D. Fedina, Yana V. Simakova, Dmitry Yu. Pushkar, Alexander L. Gintzburg
Publikováno v:
Antibiotics, Vol 13, Iss 6, p 476 (2024)
In order to combat resistance, it is necessary to develop antimicrobial agents that act differently from conventional antibiotics. Fluorothiazinone, 300 mg tablet (The Gamaleya National Research Center), is an original antibacterial drug based on a n
Externí odkaz:
https://doaj.org/article/043de55f79c045a48b591e6076e0c557
Autor:
Elizaveta S. Darnotuk, Andrei E. Siniavin, Natal’ya S. Shastina, Sergey I. Luyksaar, Anna M. Inshakova, Natalia E. Bondareva, Sergey A. Zolotov, Nadezhda L. Lubenec, Anna B. Sheremet, Denis Y. Logunov, Nailya A. Zigangirova, Vladimir A. Gushchin, Alexander L. Gintsburg
Publikováno v:
Pharmaceuticals, Vol 17, Iss 1, p 35 (2023)
The spread of COVID-19 infection continues due to the emergence of multiple transmissible and immune-evasive variants of the SARS-CoV-2 virus. Although various vaccines have been developed and several drugs have been approved for the treatment of COV
Externí odkaz:
https://doaj.org/article/145647bfa7264703919cf346a03d2fd3
Autor:
M. V. Savitskii, N. E. Moskaleva, N. A. Zigangirova, A. V. Soloveva, A. B. Sheremet, N. E. Bondareva, N. L. Lubenec, N. V. Pyatigorskaya, S. A. Appolonova
Publikováno v:
Journal Biomed. 19:73-84
We studied the pharmacokinetics, tissue availability and metabolism of fluorothiazinon, a novel antivirulence drug, in mouse blood, liver, kidneys and lungs by administering the substance intragastrically at dose of 400 mg/kg. Fluorothiazinon was est
Autor:
S. V. Tsarenko, N. A. Zigangirova, A. V. Soloveva, N. E. Bondareva, E. A. Koroleva, A. B. Sheremet, L. N. Kapotina, N. V. Shevlyagina, S. G. Andreevskaya, V. G. Zhukhovitsky, E. V. Filimonova, A. L. Gintsburg
Publikováno v:
The Journal of Antibiotics.
Autor:
Nataliya E. Bondareva, Anna V. Soloveva, Anna B. Sheremet, Ekaterina A. Koroleva, Lidiya N. Kapotina, Elena Y. Morgunova, Sergei I. Luyksaar, Egor S. Zayakin, Nailya A. Zigangirova
Publikováno v:
The Journal of Antibiotics
The high prevalence of multidrug-resistant Acinetobacter baumannii has emerged as a serious problem in the treatment of nosocomial infections in the past three decades. Recently, we developed a new small-molecule inhibitor belonging to a class of 2,4
Autor:
D. V. Balunets, Anna B. Sheremet, Nesterenko Ln, Alexandr L Gintsburg, Egor S. Zayakin, Sergey I Luyksaar, Zigangirova Na, Anna V Soloveva
Publikováno v:
The Journal of Antibiotics. 74:244-254
Therapeutic strategies that target bacterial virulence have received considerable attention. The type III secretion system (T3SS) is important for bacterial virulence and represents an attractive therapeutic target. Recently, we developed a new small
Publikováno v:
Molecular Genetics, Microbiology and Virology. 35:1-13
Pseudomonas aeruginosa is one of the leading antibiotic-resistant gram-negative organisms responsible for nosocomial infections. Multidrug pathogen resistance leads to the low antibiotic therapy efficiency. The solution for this problem involves deve
Autor:
Nailya A, Zigangirova, Ludmila N, Nesterenko, Anna B, Sheremet, Anna V, Soloveva, Sergey I, Luyksaar, Egor S, Zayakin, Denis V, Balunets, Alexandr L, Gintsburg
Publikováno v:
The Journal of antibiotics. 74(4)
Therapeutic strategies that target bacterial virulence have received considerable attention. The type III secretion system (T3SS) is important for bacterial virulence and represents an attractive therapeutic target. Recently, we developed a new small
Publikováno v:
Molecular Genetics Microbiology and Virology (Russian version). 38:3
Autor:
Kobets Nv, Alexander L. Gintsburg, Nesterenko Ln, Egor S. Zayakin, Sergei I. Luyksaar, Anna B. Sheremet, Zigangirova Na, Lydia N. Kapotina
Publikováno v:
BioMed Research International, Vol 2018 (2018)
BioMed Research International
BioMed Research International
Pseudomonas aeruginosais a cause of high mortality in burn, immunocompromised, and surgery patients. High incidence of antibiotic resistance in this pathogen makes the existent therapy inefficient. Type three secretion system (T3SS) is a leading viru